Triangle and Deepwise Medical are on the list of "Top 100 Most Valuable AI Enterprises in China...

Recently, the 2019 China Artificial Intelligence Summit (CAIS 2019) was grandly held in Nanjing. At the meeting, the list of "Top 100 Most Valuable AI Enterprises in China in 2019" was announced. The "triangle beast" and "Deepwise Medical" of Hongtai Family members On the list.

The summit was hosted by the China Artificial Intelligence Industry Development Alliance (AIIA), China Information and Communication Research Institute (CAICT), Nanjing Municipal Bureau of Industry and Information Technology, and nearly a thousand academic and business experts from Stanford University, SK Group, and Microsoft attended the summit. .

In March this year, the government proposed the development of "intelligence +" at the two sessions to deepen the R&D and application of artificial intelligence. Seize strategic opportunities to build strong productive forces in the future, so that "technical independence" is not only a proposition of the times, but also an industry driving force.

Since this year, in the field of artificial intelligence, in addition to voice recognition, visual recognition and other technologies that are at the forefront of world development, the IC industry has experienced an unprecedented vigorous rise, AIoT has entered a new commercial track, and more artificial intelligence industries The close integration of technology and commercial applications has stabilized the infrastructure of the AI ecosystem.

For this reason, the list of "Top 100 Most Valuable AI Enterprises in China in 2019" is different from last year, but it further emphasizes the deep integration of technology and market, focusing on enterprise valuation, R&D ratio, number of patents, team background, etc. The fifteen dimensions within the group were evaluated by the jury through the method of registration and selection. The enterprises and institutions were evaluated in terms of technological innovation, economic contribution and brand value, covering deep learning, autonomous driving, computer vision, cloud 100 companies in the fields of services, AI chips, big data intelligent hardware, investment institutions, etc., aim to provide more reference for the deep development of the industry, and comprehensively promote the integration and co-promotion of technology and business environment.

Triangle and Deepwise Medical are on the list of "Top 100 Most Valuable AI Enterprises in China in 2019"! (figure 2)

Triangle beast

Triangle Beast was established in February 2016 and is a leading provider of artificial intelligence semantic solutions in China. The company has always focused on the research and development and commercialization of natural language understanding and human-computer dialogue technology. With strong technical strength in semantic understanding, open domain dialogue system, and multi-round dialogue, it provides smart screen recognition solutions, dialogue interaction platforms and intelligent customer service solution. The three solutions are aimed at all scenarios, multi-domain users and vertical industries, comprehensively improving user experience, improving interaction efficiency, and reducing operating costs.

Deepwise Medical

Deepwise Medical was established in March 2017 and originated from the Peking University Artificial Intelligence Innovation Center. Various medical service organizations provide artificial intelligence and Internet medical solutions, leading the industry in early screening and accurate diagnosis of various malignant diseases.

In the artificial intelligence circuit, Hong Tai has made a systematic layout earlier, and the awards of Tricer and Deepwise Medical reflect Hong Tai's investment ability and layout in the field of AI. Among the 50+ Hongtai AI invested companies, the subsequent financing rate is as high as 70%, and the head advantage is prominent.

Currently, Hongtai Capital Holdings has established a full life cycle investment management platform. Its equity investment segment runs through angels, VC, PE, mergers and acquisitions, mother funds, etc. As of now, Hongtai has achieved a fund management scale of nearly 30 billion yuan. Its early investment focused on artificial intelligence/big data, intelligent manufacturing (advanced manufacturing), new consumption, new culture, etc.; the middle and late investment focused on advanced manufacturing, medical health, consumption and education.